MemScan

MemScan is developing a diagnostic method that combines artificial intelligence, fractal analysis, and electroretinography, using a proprietary algorithm, artificial intelligence (AI) and Machine Learning (ML) for the purposes of accurately diagnosing cognitive impairment as early as possible. The technology suite was developed by a clinical team based at the University of Miami Miller School of Medicine and the Bascom Palmer Eye Institute, one of the world’s top eye and vision research centers.